Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00805870 · ClinicalTrials.gov registry record · Phase 2
The Effects of High Dose Fish Oil Supplementation on Delayed Onset Muscle Soreness and Inflammatory Markers
A Phase 2 study, sponsored by Western Michigan University.
- Completed
- Registry status
- Phase 2
- Development phase
- 20
- Enrollment target
NCT00805870: Completed Phase 2 study, sponsored by Western Michigan University.
NCT00805870 is a Phase 2 study that has completed, run by Western Michigan University. The registered enrollment target is 20 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (85% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00805870, a Phase 2 study, has completed, sponsored by Western Michigan University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the effects of fish oil supplementation (Lovaza, GlaxoSmithKline) on muscle strength, muscle soreness and inflammation following exercise.
Primary Outcome
Quadriceps muscle strength is the maximal amount of force that the quadriceps muscles can produce during isometric knee extension exercise.
Interventions
- DRUG Lovaza (omega-3-acid ethyl esters)
- DRUG Wheat Germ Oil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2009-03 |
| Est. Completion | 2010-02 |
| Phase | Phase 2 |
What the finished NCT00805870 record still lists
NCT00805870 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (85% lower).
The record links to 0 conditions, and to 2 interventions - of which Lovaza (omega-3-acid ethyl esters) is the first listed.
NCT00805870 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00805870 about?
NCT00805870 is a clinical study titled "The Effects of High Dose Fish Oil Supplementation on Delayed Onset Muscle Soreness and Inflammatory Markers". The purpose of this study is to determine the effects of fish oil supplementation (Lovaza, GlaxoSmithKline) on muscle strength, muscle soreness and inflammation following exercise.
What is the current status of trial NCT00805870?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 20 participants. The study started on 2009-03. Estimated completion is 2010-02.
What interventions are being tested in trial NCT00805870?
The interventions under investigation include: Lovaza (omega-3-acid ethyl esters) (DRUG), Wheat Germ Oil (DRUG).
Who is sponsoring clinical trial NCT00805870?
This trial is sponsored by Western Michigan University, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00805870's enrollment target sits among peer trials
20 1805th of 2000 higher than 107 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia